ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

2-Hydroxyethyl 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-yl butanedioate → Cyclosporine TPGS

HRID 442622
印刷

反応式

HRID 442622 の反応式
[CH3:1][CH2:2][C@@H:3]1[NH:46][C:44](=[O:45])[C@H:43]([C@H:47]([OH:54])[C@@H:48]([CH2:50]/[CH:51]=[CH:52]/[CH3:53])[CH3:49])[N:42]([CH3:55])[C:40](=[O:41])[C@H:39]([CH:56]([CH3:58])[CH3:57])[N:38]([CH3:59])[C:36](=[O:37])[C@H:35]([CH2:60][CH:61]([CH3:63])[CH3:62])[N:34]([CH3:64])[C:32](=[O:33])[C@H:31]([CH2:65][CH:66]([CH3:68])[CH3:67])[N:30]([CH3:69])[C:28](=[O:29])[C@@H:27]([CH3:70])[NH:26][C:24](=[O:25])[C@H:23]([CH3:71])[NH:22][C:20](=[O:21])[C@H:19]([CH2:72][CH:73]([CH3:75])[CH3:74])[N:18]([CH3:76])[C:16](=[O:17])[C@H:15]([CH:77]([CH3:79])[CH3:78])[NH:14][C:12](=[O:13])[C@H:11]([CH2:80][CH:81]([CH3:83])[CH3:82])[N:10]([CH3:84])[C:8](=[O:9])[CH2:7][N:6]([CH3:85])[C:4]1=[O:5].[CH3:86][C:87]1[C:92]([CH3:93])=[C:91]([O:94][C:95]([CH2:97][CH2:98][C:99]([O:101][CH2:102][CH2:103][OH:104])=[O:100])=[O:96])[C:90]([CH3:105])=[C:89]2[CH2:106][CH2:107][C:108]([CH2:111][CH2:112][CH2:113][CH:114]([CH2:116][CH2:117][CH2:118][CH:119]([CH2:121][CH2:122][CH2:123][CH:124]([CH3:126])[CH3:125])[CH3:120])[CH3:115])([CH3:110])[O:109][C:88]=12>C(O)C>[CH3:1][CH2:2][C@@H:3]1[NH:46][C:44](=[O:45])[C@H:43]([C@H:47]([OH:54])[C@@H:48]([CH2:50]/[CH:51]=[CH:52]/[CH3:53])[CH3:49])[N:42]([CH3:55])[C:40](=[O:41])[C@H:39]([CH:56]([CH3:57])[CH3:58])[N:38]([CH3:59])[C:36](=[O:37])[C@H:35]([CH2:60][CH:61]([CH3:62])[CH3:63])[N:34]([CH3:64])[C:32](=[O:33])[C@H:31]([CH2:65][CH:66]([CH3:68])[CH3:67])[N:30]([CH3:69])[C:28](=[O:29])[C@@H:27]([CH3:70])[NH:26][C:24](=[O:25])[C@H:23]([CH3:71])[NH:22][C:20](=[O:21])[C@H:19]([CH2:72][CH:73]([CH3:75])[CH3:74])[N:18]([CH3:76])[C:16](=[O:17])[C@H:15]([CH:77]([CH3:79])[CH3:78])[NH:14][C:12](=[O:13])[C@H:11]([CH2:80][CH:81]([CH3:83])[CH3:82])[N:10]([CH3:84])[C:8](=[O:9])[CH2:7][N:6]([CH3:85])[C:4]1=[O:5].[CH3:86][C:87]1[C:92]([CH3:93])=[C:91]([O:94][C:95]([CH2:97][CH2:98][C:99]([O:101][CH2:102][CH2:103][OH:104])=[O:100])=[O:96])[C:90]([CH3:105])=[C:89]2[CH2:106][CH2:107][C:108]([CH2:111][CH2:112][CH2:113][CH:114]([CH2:116][CH2:117][CH2:118][CH:119]([CH2:121][CH2:122][CH2:123][CH:124]([CH3:126])[CH3:125])[CH3:120])[CH3:115])([CH3:110])[O:109][C:88]=12
参加物実験手順後処理出典と根拠反応ノート

参加物

4

反応物 2

HCID 714062-Hydroxyethyl 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-yl butanedioate3 回HCID 5284373Cyclosporin A3 回

生成物 1

HCID 131721213Cyclosporine TPGS

試薬・触媒・溶媒 1

HCID 702Ethanol溶媒
2 回

実験手順

200 mg of Cyclosporine was weighed into a 100 ml beaker and 1.2 grams of Vitamin E TPGS was added, and to this was added 8 grams of ethanol. The ethanol solvent, Cyclosporine, and TPGS were stirred at room temperature for 10 minutes until the Cyclosporine and TPGS components were clearly dissolved. The solvent was evaporated from a Petri dish overnight and the sample was examined under an Olympus BX50 microscope at 200× magnification by adding a small quantity of water to the cyclosporine/TPGS, and watching for visible crystals. No crystals were observed, only a clear solution was obtained. It was therefore concluded that solvent evaporation will also work to produce clear solutions of Cyclosporine/TPGS when added to water.

後処理

  1. additionwas added
  2. dissolutionwere clearly dissolved
  3. customThe solvent was evaporated from a Petri dish overnight
  4. additionby adding a small quantity of water to the cyclosporine/TPGS
  5. customonly a clear solution was obtained
  6. customIt was therefore concluded that solvent evaporation

出典と根拠

ORDレコード
ord-cf4bd562a0e54fbb9f1accaee1a62c28
出典データセット
uspto-grants-1999_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US05891845

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート